Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population-based cohort study

被引：0
|
作者：
Islam, Nehal [1 ]
Filion, Kristian B. [2 ]
Yu, Oriana H. Y. [3 ]
Douros, Antonios [4 ]
Reynier, Pauline [3 ]
机构：
[1] McGill Univ, Fac Med & Hlth Sci, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[4] Charite, Inst Clin Pharmacol & Toxicol, Berlin, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
663
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [1] Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population-based cohort study
    Islam, Nehal
    Reynier, Pauline
    Douros, Antonios
    Yu, Oriana H. Y.
    Filion, Kristian B.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1523 - 1533
  • [2] Sulfonylureas and the Risk of Adverse Cardiovascular Events Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
    Filion, Kristian B.
    Azoulay, Laurent
    Yin, Hui
    Yu, Oriana H.
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 46 - 46
  • [3] Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies
    Islam, Nehal
    Ayele, Henok T.
    Yu, Oriana H. Y.
    Douros, Antonios
    Filion, Kristian B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (06) : 1248 - 1257
  • [4] Warfarin and sulfonylureas in individuals with type 2 diabetes and risk of bleeding: A UK population-based cohort study
    Alwafi, Hassan Hasan
    Naser, Abdallah
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 276 - 277
  • [5] Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
    Dimakos, Jenny
    Cui, Ying
    Platt, Robert W.
    Renoux, Christel
    Filion, Kristian B.
    Douros, Antonios
    DIABETES CARE, 2023, 46 (02) : 377 - 383
  • [6] Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study
    Wu, Hongjiang
    Walker, Jeremy
    Damhuis, Ronald A.
    Brewster, David H.
    Wild, Sarah H.
    LUNG CANCER, 2016, 99 : 194 - 199
  • [7] Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study
    Filion, Kristian B.
    Douros, Antonios
    Azoulay, Laurent
    Yin, Hui
    Yu, Oriana H.
    Suissa, Samy
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (10) : 2378 - 2389
  • [8] The Effect of Metformin Versus Sulfonylurea on the Risk of Tuberculosis Disease in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
    Su, W.
    Pan, S.
    Yen, Y.
    Su, V.
    Chuang, P.
    Feng, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Comparing the Risk for Atrial Fibrillation in Patients with Diabetes Initiating Metformin or Sulfonylureas: A Nationwide Population-Based Cohort Study in Taiwan
    Liu, Ying Ling
    Chiang, Chi Wen
    Tsai, Tong Rong
    Tsai, Wei Chung
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 371 - 371
  • [10] Sulfonylureas and the risk of ventricular arrhythmias among patients with type 2 diabetes: A systematic review of observational studies
    Islam, Nehal
    Ayele, Henok Tadesse
    Douros, Antonios
    Yu, Oriana
    Filion, Kristian B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 344 - 345
12345